The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Correlation between universal BCG vaccination policy and reduced mortality for COVID-19
Open accessAbstract
COVID-19 has spread to most countries in the world. Puzzlingly, the impact of the disease varies in different countries. This variation is attributed to differences in cultural norms, mitigation efforts, and health infrastructure. Here, we propose that national differences in COVID-19 impact could be partially explained by different national policies with respect to Bacillus Calmette-Guérin (BCG) vaccination. BCG vaccination has been reported to offer broad protection from other respiratory infections besides tuberculosis. We compared BCG vaccination policies with the morbidity and mortality for COVID-19 for middle-high and high-income countries. We found that countries without universal policies of BCG vaccination (Italy, the Netherlands, USA) have been more severely affected compared to countries with universal and long-standing BCG policies. The difference cannot be accounted for by differences in disease onset, adoption of early social distancing policies, state of health services, nor income level. Reduced mortality suggests BCG vaccination could be a potential new tool in the fight against COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Trained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
Kleinnijenhuis, J., Quintin, J., Preijers, F., Benn, C. S., Joosten, L. A. B., Jacobs, C., van Loenhout, J., Xavier, R. J., Aaby, P., van der Meer, J. W. M., et al. (2014) · Journal of Innate Immunity · doi:10.1159/000355628 · Cited by 620
The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
Zwerling, A., Behr, M. A., Verma, A., Brewer, T. F., Menzies, D., & Pai, M. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001012 · Cited by 575
Non-specific effects of BCG vaccine on viral infections
Moorlag, S. J. C. F. M., Arts, R. J. W., van Crevel, R., & Netea, M. G. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.020 · Cited by 479
BCG immunotherapy of bladder cancer: 20 years on
Alexandroff, A. B., Jackson, A. M., O'Donnell, M. A., & James, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07422-4 · Cited by 471
SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics
Cao, Q., Chen, Y.-C., Chen, C.-L., & Chiu, C.-H. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.02.009 · Cited by 411
Kristensen, I., Aaby, P., Jensen, H., & Fine, P. (2000) · BMJ · doi:10.1136/bmj.321.7274.1435 · Cited by 404
Long-term Efficacy of BCG Vaccine in American Indians and Alaska Natives: A 60-Year Follow-up Study
Aronson, N. E., Santosham, M., Comstock, G. W., Howard, R. S., Moulton, L. H., Rhoades, E. R., & Harrison, L. H. (2004) · JAMA · doi:10.1001/jama.291.17.2086 · Cited by 338
Does the efficacy of BCG decline with time since vaccination?
Sterne, J. A. C., Rodrigues, L. C., & Guedes, I. N. (1998) · PubMed · Cited by 310
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
Hamiel, U., Kozer, E., & Youngster, I. (2020) · JAMA · doi:10.1001/jama.2020.8189 · Cited by 211
Berg, M. K., Yu, Q., Salvador, C. E., Melani, I., & Kitayama, S. (2020) · Science Advances · doi:10.1126/sciadv.abc1463 · Cited by 158
CD4 T-Cell-Mediated Heterologous Immunity between Mycobacteria and Poxviruses
Mathurin, K. S., Martens, G. W., Kornfeld, H., & Welsh, R. M. (2009) · Journal of Virology · doi:10.1128/jvi.02393-08 · Cited by 134
Usher, N. T., Chang, S., Howard, R. S., Martinez, A., Harrison, L. H., Santosham, M., & Aronson, N. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.12014 · Cited by 101
Differential COVID-19-attributable mortality and BCG vaccine use in countriesPreprint
Shet, A., Ray, D., Malavige, N., Santosham, M., & Bar‐Zeev, N. (2020) · medRxiv · doi:10.1101/2020.04.01.20049478 · Cited by 98
Komine‐Aizawa, S., Yamazaki, T., Yamazaki, T., Hattori, S.-I., Miyamoto, Y., Yamamoto, N., Haga, S., Sugitani, M., Honda, M., Hayakawa, S., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00190-10 · Cited by 12
Cited by
Zimmermann, P., & Curtis, N. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-320338 · Cited by 502
Is ethnicity linked to incidence or outcomes of covid-19?
Khunti, K., Singh, A. K., Pareek, M., & Hanif, W. (2020) · BMJ · doi:10.1136/bmj.m1548 · Cited by 493
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
Netea, M. G., Giamarellos-Bourboulis, E. J., Domínguez-Andrés, J., Curtis, N., van Crevel, R., van de Veerdonk, F. L., & Bonten, M. (2020) · Cell · doi:10.1016/j.cell.2020.04.042 · Cited by 468
Coronavirus vaccine development: from SARS and MERS to COVID-19
Li, Y.-D., Chi, W.-Y., Su, J.-H., Ferrall, L., Hung, C.-F., & Wu, T.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00695-2 · Cited by 453
Self-citationStawicki, S., Jeanmonod, R., Miller, A., Paladino, L., Gaieski, D., Yaffee, A., De Wulf, A., Grover, J., Papadimos, T., Bloem, C., et al. (2020) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_86_20 · Cited by 373
Self-citation
Metadata
- Authors
- Miller, A., Reandelar, M. J., Fasciglione, K., Roumenova, V., Li, Y., & Otazu, G. H.
- Venue
- medRxiv
- Publisher
- openRxiv
- Published
- 2020-03-28
- OpenAlex
- W3014081291
- Cited by
- 506
- References
- 16
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.